This means another local plant may end up with Indian owners, after Terapia Cluj got Indian shareholders in 2006. Sanofi put its generics division up for sale in 2016.
“We can confirm we received letters of interest for the acquisition of the European generics division from strategic and financial investors,” Sanofi representatives told ZF.
Sanofi will not reveal any details about the preparations for the sale and will not provide further comment on the issue, they added.
Zentiva posted 415.72 million lei (EUR89 million) revenue in 2016, up 5% on 2015 and RON72.4 million net profit, compared with RON46.19 million in the previous year.
Torrent Pharma has been operating in Romania via subsidiary since 2010 and its revenue fell to RON36 million in 2016 from RON81 million in 2015, according to publicly available information. (EUR1=RON4.6607)
(English version by Loredana Fratila-Cristescu)